Alyssa Peckham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rhode IslandPharmD, 2014
Publications & Presentations
PubMed
- 15 citationsPolicies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?Alyssa M. Peckham, Kathleen A. Fairman, David A. Sclar
Expert Opinion on Drug Safety. 2018-05-01 - 61 citationsGabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilanceAlyssa M. Peckham, Maria J Ananickal, David A. Sclar
Risk Management and Healthcare Policy. 2018-08-17 - 35 citationsPredictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. PopulationAlyssa M. Peckham, Kirk E. Evoy, Jordan R. Covvey, Leslie Ochs, Kathleen A. Fairman
Pharmacotherapy. 2018-04-01
Office
19555 N 59th Ave
Cholla Hall, Office 201-1
Glendale, AZ 85308Phone+1 401-529-7059
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
